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Abstract
Background:  Few comparative studies of clinical ethics consultation practices have been
reported. The objective of this study was to explore how American and Japanese experts analyze
an Alzheimer's case regarding ethics consultation.
Methods: We presented the case to physicians and ethicists from the US and Japan (one expert
from each field from both countries; total = 4) and obtained their responses through a
questionnaire and in-depth interviews.
Results: Establishing a consensus was a common goal among American and Japanese participants.
In attempting to achieve consensus, the most significant similarity between Japanese and American
ethics consultants was that they both appeared to adopt an "ethics facilitation" approach.
Differences were found in recommendation and assessment between the American and Japanese
participants. In selecting a surrogate, the American participants chose to contact the grandson
before designating the daughter-in-law as the surrogate decision-maker. Conversely the Japanese
experts assumed that the daughter-in-law was the surrogate.
Conclusion: Our findings suggest that consensus building through an "ethics facilitation" approach
may be a commonality to the practice of ethics consultation in the US and Japan, while differences
emerged in terms of recommendations, surrogate assessment, and assessing treatments. Further
research is needed to appreciate differences not only among different nations including, but not
limited to, countries in Europe, Asia and the Americas, but also within each country.
Background
Ethics consultation is a service provided by an individual
or a group to help patients, families, surrogates, health-
care providers, or other involved parties address uncer-
tainty or conflict regarding value-laden issues that emerge
in healthcare [1]. In the United States (US), ethics consul-
tation services have rapidly expanded since the 1980s; cur-
rently, this service is provided at all hospitals with 400 or
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more beds. Thirty-six thousand cases are requested yearly,
involving roughly 29,000 consultants [2]. Several studies
on ethics consultation have been published in the US,
including discussions based on case studies [3,4], evalua-
tions of ethics consultation [5,6], and analyses of consul-
tation recommendations and their relevant factors [7,8].
Recently reports on ethics consultation have also been
published in countries such as Australia, Canada, Italy,
Japan, Germany, Norway, Switzerland and the UK [9-15].
These reports highlight a diversity in modality of clinical
ethics consultation among and even within different
nations. However, there is very little international com-
parative research that identifies similarities and differ-
ences in ethics consultation.
The practice of ethics consultation has often depended on
clinical ethical judgments and practical knowledge. Even
in the US, 95% of the individuals performing ethics con-
sultation have not completed any formal graduate level
training [2]. Comparisons based on case studies are there-
fore an appropriate means of beginning to assess the sim-
ilarities and differences in practical knowledge that guide
ethics consultation in diverse international contexts.
The objective of this study was to explore how American
and Japanese experts analyze an Alzheimer's case regard-
ing ethics consultation. This case focused on the nutri-
tional management of an elderly Alzheimer's patient. We
used this case because a review of the literature showed
that it has certain key elements that are likely to provoke
dilemma or controversy among healthcare practitioners:
the patient is incompetent, there are questions about
whether or not to opt for terminal care, and disagreements
easily arise among the interested parties [16,17]. In this
paper, we analyze the recommendations and approaches
of ethics consultants from the US and Japan concerning
this case and also discuss the legal and institutional
aspects of terminal care issues that are presented. Because
it is necessary to identify practical knowledge in ethics
consultation, this study may assist in educating ethics
consultants.
Methods
Study Design
We chose experts from both the US and Japan and con-
ducted our research from July to August 2006 using a
questionnaire survey, followed by expert interviews. We
divided the participants into American and Japanese
teams, had them examine the case of an Alzheimer's
patient, and conducted follow-up interviews. Participants
were told to approach the case as if it occurred in their
respective countries. We conducted a content analysis of
the teams' approaches and conclusions. All the interviews
were performed by three authors of this paper (NN, YN,
MF). The study was approved by the Ethics Committee of
the Graduate School of Medicine, University of Tokyo.
Participants
Participants were recruited from among researchers who
have published several reports on ethics consultation,
medical ethics, and bioethics in academic journals. Many
of the individuals practicing ethics consultation in the US
are healthcare workers, chaplains, or ethicists [2], while
ethics consultation in Japan is often performed by physi-
cians and ethicists. We therefore selected four experts
from the fields of medicine and ethics from the US and
Japan as participants (Table 1). All participants were male.
We explained to all participants their role in this study
and received their consent in writing.
The Japanese participants tended to have fewer years of
ethics consultation experience and have handled a smaller
number of cases. This was because ethics consultation in
Japan has only been initiated in recent years. The Japanese
participants selected for this study, however, had been
active in research and clinical ethics consultation. Physi-
cian C, for example, had undertaken research on topics
such as advance directives; and ethicist D had undertaken
research on medical ethics education. It was therefore
appropriate to regard physician C and ethicist D as experts
in ethics consultation for the purposes of this explorative
study.
Table 1: Participant's Demographic Information
Attributes Physician A Ethicist B Physician C Ethicist D
Nationality United States United States Japan Japan
Specialization medicine/psychiatry ethics medicine/internal 
medicine
ethics
Professional degree M.D. PhD in philosophy M.D. MA in philosophy
Affiliation university university/hospital general hospital university
Number of available hospital 
beds
university hospital 
500–600 beds
polyclinic hospital 700 beds general hospital 110 
beds
university hospital, mid-size 
general hospital 200–300 beds
Years of experience about 20 about 11 about 1 about 4
Total number of cases 
experienced
more than 500 about 250 about five about 400BMC Medical Ethics 2008, 9:2 http://www.biomedcentral.com/1472-6939/9/2
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Data Collection
1. Questionnaire: The questionnaire asked participants
about their affiliations and ethics consultation experi-
ences, to describe some of the typical cases they have han-
dled, and included questions related to Alzheimer's
patients (patient competency, surrogates, and selection of
treatment methods). We created an interview guide based
on the responses received in the questionnaire.
2. Expert interview: We conducted a semi-structured
expert interview with each participant based on the results
of the questionnaire. The expert interview was designed to
increase our understanding of the technical and practical
knowledge of professionals from that specialty. Accord-
ingly, the interviewee is not merely treated as a case, but
as an expert within that particular field [18]. During this
interview, we asked the participants how they receive
requests for ethics consultation and how they assist and
advise their clients. We also asked the participants about
the Alzheimer's case, including their recommendation,
surrogate evaluation, and treatment assessment.
3. Team case study: We had the four experts divide into
two respective teams – one from the US and one from
Japan. The two teams individually discussed the case
before submitting their recommendation in writing. The
teams first exchanged their written recommendation for
this case and then met to comment on and discuss each
other's recommendation. The Japanese and American
team members neither knew each other nor had conversa-
tions regarding bioethical issues prior to this study.
4. Follow-up interview: We conducted a semi-structured
follow-up interview based on the recommendations of
the two teams. We interviewed each participant concern-
ing how they developed their recommendation for the
Alzheimer's case as a member of a two-party team.
The questionnaire and case were first developed in Japa-
nese and then translated into English. We confirmed the
accuracy of translation by performing a native check and
back-translation. The interview was done in the partici-
pant's native language and was recorded with their
informed consent. We interviewed each participant for
three to four hours in total.
Data Analysis
The entire interviews were transcribed verbatim and ana-
lyzed using content analysis [18,19]. Initially one of the
authors (NN) coded the data by keyword (eg, futility of
nutrient treatment, evaluation of terminal stage Alzhe-
imer's disease) and then further coded those keywords
into categories (eg, treatment assessments). The sets of
keywords and categories along with the initial data were
reviewed by two other coauthors (YN, MF). The three
authors discussed any discretion regarding the interpreta-
tion of the data and reached a consensus.
Case
The case presented below is fictional, but is based on an
actual case from Japan. The case is considered typical of
ethics consultation cases in both the US and Japan, based
on the data collected from the interview and question-
naire, and review of the published literature [2,20].
Patient Details and Consultation Request
A psychiatrist at N City General Hospital visits an ethics
consultant with an ethical dilemma and requests consul-
tation services.
Explanation by the Physician (Table 2, Figure 1)
Explanation by the physician is summarized in Table 2
and Figure 1.
Family's Explanation
I have taken care of my mother-in-law, Mrs. Mineko
Sakata, and I know that her love-of-life derives much from
food. I feel that to force her to live without the ability to
eat would be inappropriate. For Mineko, the fact that she
can no longer eat signifies the end of her life. I really do
not want Mineko to have any further invasive medical
treatments because she is so old. I am just her daughter-in-
law, and the widow of her son, so I'm quite reluctant to
make the final decision. Joji, my son, was not very close to
his grandmother and did not take much interest in caring
for her while she was at home. He also hasn't come to visit
her that often here at the hospital. Mineko only has us left
as living relatives since her sisters have already passed
away.
Family tree of the case Figure 1
Family tree of the case. White square means Male. White 
circle means Female. Black squares and circles mean Dead. 
Dot circle signifies 'Living together.'
Mrs. Fujiko Sakata
Age=68
Mr. Joji Sakata Age=40
Currently staying in U.S. for business
=Male
=Female
=Dead
=Living togetherBMC Medical Ethics 2008, 9:2 http://www.biomedcentral.com/1472-6939/9/2
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Results
The central problem in this case was that there were con-
flicts of opinion within the family and between the family
and the physician. These arose, in part, because the
patient had not indicated her own intentions. The results
of our analysis showed that because the preference of the
patient is unclear in this case, the patient's wishes are dis-
cerned by gathering information and establishing a con-
sensus in her best interests. However, the
recommendations of the American and Japanese experts
differed, based on their surrogate evaluation and treat-
ment assessment. The recommendations of the two teams
are as follows:
1. Recommendations
American team
The patient be provided with "comfort measures only"
(do not resuscitate; comfort care) in accord with pallia-
tion or comfort as an appropriate goal for care at this time.
Members of the care team and Mrs. Fujiko Sakata again
attempt to contact Mr. Joji Sakata in the hope that he will
come to visit his grandmother in her last days and console
his mother.
Japanese team
Treatments for oral intake could be explored by a nutri-
tion support team (NST) (if an NST is unavailable, treat-
ment could be explored by a team including an attending
nurse and a registered dietitian or speech therapist) com-
bined with the use of a peripheral intravenous drip.
Two differences are clear between these recommenda-
tions: contact with the grandson, and the method of treat-
ment. First, the American and Japanese participants
differed on whether or not to contact the grandson
(daughter-in-law's son). The experts from the US stated
that it was important to contact the grandson. The Japa-
nese team, however, assumed that the daughter-in-law
was the surrogate and did not advise contacting the grand-
son. Second, the recommendations of the two teams with
respect to the question of appropriate treatment differed.
The experts from the US advised ceasing nutrient treat-
ment and recommended palliative care. In contrast, those
from Japan advised the provision of nutrient treatment by
oral intake with the aid of a NST or a peripheral intrave-
nous drip. To understand these differences, we examined
surrogate evaluation and treatment assessment.
2. Surrogate Evaluation
All four American and Japanese experts said that the
patient of this case was not competent for decision-mak-
ing. The four experts concurred that it was important to
respect the wishes of the surrogate as much as possible
provided that he or she was focused on the patient's
wishes and not on his/her own values and preferences.
For both teams, surrogate evaluation consisted of the
common factor of selecting one who could help to iden-
tify the patient's wishes.
(1) Selection of surrogate
The Japanese team regarded the daughter-in-law, who had
a close relationship with the patient, as the key person for
surrogate decision-making. However, the American team
thought it to be best to identify not only the daughter-in-
law but also the grandson, an individual whom they con-
sidered best from a "legal standing." The reason behind
Table 2: Explanation by the Physician
Name and age Mrs. Mineko Sakata. Age = 92 SEX: Female
Diagnosis Late-onset Alzheimer's disease.
Chief complaints disturbance of consciousness, cognitive impairment, and dysphagia
[History and Episode]
The patient began to exhibit impairment of memory and orientation in 1998 and has been progressive since. Her family first brought her to our 
hospital in July 2000 when they discovered she was wandering about aimlessly and screaming in the middle of the night (ambulatory automatism). 
She was diagnosed with late-onset Alzheimer's disease. The patient fell down at home in September 2005. A local orthopedist found the patient to 
have a fracture in her left femur. Although the patient did not undergo surgery and was followed closely, she became bedridden, which made it 
difficult for her family to take care of her at home. The patient's family admitted her to X Elderly Care Facility in October 2005. While the patient 
was at the X Facility, she remained drowsy throughout the day and night. When addressed in a loud voice, she would open her eyes. She sometimes 
moans without any comprehensive utterances. The patient could not chew or swallow, which made oral feeding difficult. In July 2006, the patient 
was transferred to our hospital. Our staff has tried to tube feed her via a nasal gastric tube; but she persistently removes the tube. The patient is 
currently physically stable and is not considered to be at the end-of-life stage.
A member of our staff has indicated the possible legal and ethical problems of using only a peripheral intravenous drip (IV), since doing so would 
lead to a prognosis of death within a few weeks. We therefore did not propose the use of only an IV to her family as a possible therapy. We have 
also ruled out central venous nutrition (total parenteral nutrition using a central venous catheter), and we did not recommend it in terms of the 
patient's age, condition and the necessary invasive interventions. As a result, we recommended a gastrostomy (Percutaneous Endoscopic 
Gastrostomy: PEG) for total enteral nutrition. In the future, we plan to transfer the patient to Y hospital for elderly.
Mrs. Fujiko Sakata, the patient's daughter-in-law, has expressed that she would not want any other medical treatments if the patient were unable to 
eat. The patient also has a grandson whose name is Joji, Mrs. Fujiko Sakata's son, and who occasionally comes to visit the patient. His opinion is that 
a gastrostomy would be allowed if it can prevent his grandmother from dying of starvation. Joji is currently in the US since he has worked there for 
a long period of time.BMC Medical Ethics 2008, 9:2 http://www.biomedcentral.com/1472-6939/9/2
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this is twofold: 1) the grandson is related by blood and
thus is legally better fit as a surrogate decision-maker, yet
lives far away and has little relationship with the patient,
and 2) the daughter-in-law lives close by and has a good
relationship with the patient, yet is unrelated by blood
and thus has less legal right to make surrogate decisions.
In addition, the experts from the US understood that the
daughter-in-law wanted to include the grandson in choos-
ing a treatment. Consequently, to select an appropriate
surrogate, the American team thought it to be best to con-
tact the grandson. According to physician A:
I think in the United States, the grandson would have greater
legal standing as a surrogate than the daughter-in-law. ... (But
on the other hand,) the grandson, from a moral perspective, he
really doesn't deserve to have the role of surrogate, so you have
this conflict between the law, the literal interpretation of the
law and what seems to be right here, and so I would very much
try to get the daughter-in-law and the son and the grandson to
come to some conclusion together...
On the other hand, the Japanese team recommended that
only the daughter-in-law should be chosen as the surro-
gate. Given that there is no legal barrier to the daughter-
in-law to be a surrogate decision-maker, the experts from
Japan were not particularly concerned about contacting
the grandson and did not treat this as an important issue.
Their reasoning was that the daughter-in-law understood
the wishes of the patient and thus can act as a suitable
decision-maker. For example, ethicist D considered the
daughter-in-law to be the best person given her relation-
ship with the patient.
Certainly, the daughter-in-law would be the best candidate to
make decisions for the patient. I mean they had a good relation-
ship, didn't they. In all and all, the amount of time spent with
each other determines a lot about a relationship. It's not like we
could just ignore her opinion. If we had to pick between the
grandson and her, I would think that she would be the best per-
son.
3. Treatment Assessment
Treatment assessment involved the futility of nutrient
treatments and evaluation of terminal disease.
(1) Futility of Nutrient Treatment
The experts from the US thought that technical provision
of nutrition and hydration was medically ineffective and
therefore unnecessary in this case. Physician A stated.
I think it's futile because preserving life of a severely demented
person by putting a surgically implanted tube in them is to me
pointless. I would not want this, number one. Number two,
there's some medical evidence; there's growing medical evi-
dence that it's not even effective at late stage Alzheimer's (dis-
ease) [21,22].
Based on this supportive evidence, he felt that medically
administrated nutrition and hydration simply prolongs
the dying process and is meaningless for a patient with an
advanced cognitive disease. It should be noted that the
two experts from the US were not opposed to assisted oral
feeding in the event that the patient became capable of
chewing or swallowing.
The two participants from Japan indicated that they con-
sidered the technical provision of nutrition and hydration
to be psycho-socially beneficial. Ethicist D indicated that
he was skeptical of its futility. His opinion was that "phy-
sicians in Japan do not always deny medically assisted
nutrition and hydration at the terminal stage;" rather, in
some cases it is possible to utilize it to satisfy the family's
needs. Physician C suggested the following:
Even if the patient has little awareness, or has a high degree of
mental deterioration, or is even bedridden, or does not even
speak, I think that it is socially important that the patient be
kept alive as long as the patient has family or grandchildren
who wish for such.
(2) Evaluation of Terminal-Stage Alzheimer's Disease
The American and Japanese participants varied in their
opinions on the futility of nutrient treatment concerning
this case. This most likely arose from their different per-
ceptions on the implications of terminal Alzheimer's dis-
ease. On the one hand, the Japanese participants believed
that a patient's life can be prolonged with a gastrostomy
and thus should not be considered to be "end-of-life." On
the other hand, the two experts from the US thought that
this case applied to end-of-life care based on recent evi-
dence that nutrient treatment and transfusions are not
beneficial to prolonging life [21,22]. Thus the two teams
disagreed on their interpretation of whether or not this
case should be considered to be "end-of-life" and likewise
on their recommendations regarding nutrient treatment.
The two experts from the US regarded nutrient treatment
of terminal-stage Alzheimer's patients with no hope of
regaining consciousness as unbeneficial. They regarded
terminal Alzheimer's disease, a higher-function brain dis-
order, as not significantly different from terminal cancer
or any other terminal illness. Physician A noted,
I mean people get worse and worse and their prognosis gets
worse and worse and that's true with cancer and that's true
with Alzheimer's. So I guess what I would say is if an Alzheimer
patient has two months to live, why would you want to treat
them differently than a cancer patient who has two months to
live?BMC Medical Ethics 2008, 9:2 http://www.biomedcentral.com/1472-6939/9/2
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Contrary to this, the Japanese participants regarded nutri-
ent treatment of terminal-stage Alzheimer's patients with
no hope of regaining consciousness as beneficial. This was
based on the reasoning that terminal-stage Alzheimer's
disease is medically different from terminal cancer.
Although it is difficult to restore the consciousness of ter-
minal-stage Alzheimer's patients, the maintenance of
their somatic functions is within the scope of medical
treatment. In the case of terminal cancer, however, there is
little hope of restoring physical function even given tech-
nical provision of nutrition and hydration. Subsequently,
palliative care is reserved primarily for terminal cancer
patients in Japan. The two ailments were therefore consid-
ered to be significantly different. According to physician
C,
In a case such as this (terminal stage Alzheimer's), the patient
may live for two or three more years if nutrients are actively
administered using either a PEG (percutaneous endoscopic
gatrostomy) or IVH (intravenous hyperalimentation). That
being said, no matter how much nutrition you provide to
patients with terminal cancer, they can't escape death....
4. Consensus Building
Common characteristics were evident in the two teams'
approaches to consensus building among individuals
involved in the case such as the patient, healthcare provid-
ers and possible surrogate decision-makers. The underly-
ing theme of both teams was to seek out the patient's
preferences. Ethicist D stated after a team discussion that
the approaches to consensus building were "closer than
expected" between the American and Japanese partici-
pants.
Interestingly enough, differences arose in approach
between physicians and ethicists at first, but then were
resolved within each team. That is, the physicians tended
to formulate their recommendation from the provided
information; the American physician chose palliative care,
while the Japanese physician chose peripheral intrave-
nous drip. Conversely, the ethicists had difficulty deciding
on a treatment because of a lack of information. When the
physician and ethicist of each team discussed the case and
decided on their recommendation, the results reflected
both of their opinions. For instance, physician C recom-
mended peripheral intravenous drip and ethicist D sug-
gested NST oral intake, yet both were included in the final
recommendation.
Discussion
Establishing a consensus was a common goal among
American and Japanese participants. In attempting to
achieve consensus, the most significant similarity between
Japanese and American ethics consultation teams was that
they both appeared to adopt an "ethics facilitation"
approach. As discussed in the major American report on
ethics consultation, Core Competencies for Health Care Eth-
ics Consultation, there are three broad approaches to ethics
consultation in the literature, "authoritarian," "pure facil-
itation," and "ethics facilitation"[23,24] [see Additional
file 1].
Differences were found in recommendation and assess-
ment between the American and Japanese participants. In
selecting a surrogate, the American participants chose to
contact the grandson before designating the daughter-in-
law as the decision-maker. Conversely the experts from
Japan assumed that the daughter-in-law was the surrogate.
It is interesting to note that both teams referred to Joji
Sakata differently. The experts from the US usually called
him the "grandson," because they tried to understand the
case from the perspective of the patient. In contrast, the
Japanese team tended to call him the "son" because they
perceived the daughter-in-law as the key figure. Another
difference was found in the assessment of treatments. In
short, the American participants regarded the provision of
nutrition and hydration as unbeneficial, based on medical
evidence [21,22], while the Japanese participants thought
it to be beneficial. Yet another difference was found in
each team's take on whether this case should be consid-
ered to be "end-of-life" or not.
These differences can be discussed from legal aspects of
terminal care. Following the Quinlan's case of 1975, and
based on a variety of legal precedents, withdrawing or
withholding healthcare intervention from terminal-stage
patients is permissible in the US. According to ethicist B,
the legal framework concerning end-of-life care in the US
can be summarized by the following three points: 1) a
patient's right to refuse treatment is firm, 2) a patient who
is unable to exercise her right, such as this patient, has that
right extended ideally through advance directives and a
designated surrogate, and 3) state legislation governs the
role of surrogates and/or legal ordering of surrogate deci-
sion makers, and such legislation varies from state to state.
Under these legal conditions, the important role of ethics
consultation in terminal care is first to clarify the wishes
or goals of the patient. If the patient's preference has not
been stated, the patient is not expected to regain con-
sciousness, and there is no way to ascertain the once com-
petent, now incompetent, patient's wishes, the results of
ethics consultation should reflect the best interest of the
patient.
In Japan, however, legal standards related to terminal care
are currently unclear. There are no Supreme Court prece-
dents concerned with terminal treatment, with the only
representative cases having been decided by regional
courts. We can summarize the contemporary legal inter-
pretations of terminal care, as based on the work of med-BMC Medical Ethics 2008, 9:2 http://www.biomedcentral.com/1472-6939/9/2
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ical law specialists [25], in the following two points: 1)
past decisions merely state the conditions for terminating
treatment, and 2) if those conditions are not satisfied,
then standard treatments must be provided. This Alzhe-
imer's case does not coincide with the Japanese legal con-
ditions for terminating medical care. Therefore, it is
difficult to actively terminate therapy, even nutrient treat-
ment, which only prolongs the life of late-stage Alzhe-
imer's patients in Japan. From a legal standpoint such as
this, the Japanese participants tended towards emphasiz-
ing the beneficence of the physician for performing the
minimal standard treatment, giving greater consideration
to the psycho-social aspects of nutrient treatment in this
case.
The different evaluations of terminal Alzheimer's disease
may also be triggered by the fact that different palliative
care systems exist in each country. According to the World
Health Organization (2002) [26], "palliative care is an
approach that improves the quality of life of patients and
their families facing the problems associated with life-
threatening illness." This statement presumes that all dis-
eases are targets of palliative care. In the US, hospices are
likely to treat most end-of-life diseases, whether they are a
type of cancer or not, with palliative care [27]. Criteria
have been set up in Japan to establish palliative care
wards, but these are limited to particular diseases covered
by insurance benefits such as cancer and acquired immu-
nodeficiency syndrome (AIDS); therefore, it is difficult to
provide palliative care for many other diseases. As a result,
terminal Alzheimer's patients in Japan are often not
treated as potential recipients of palliative care but usually
receive treatment in mid-size city hospitals, unlike termi-
nal cancer patients. This situation may account for the dif-
ferences in treatment evaluation between the American
and Japanese participants.
This study has several limitations. First, this study was to
provide preliminary data on how four experts from the US
and Japan approach clinical ethics consultation with a ter-
minal-stage Alzheimer's case. In so it was not a compari-
son of each country's ethics consultation practices.
Second, this study's sample was limited to four experts;
others experts from each country could provide a different
recommendation and position. Third, the background of
the participants was limited to physicians and ethicists;
likewise results may differ with consultants with different
backgrounds. Fourth, this study used a single case con-
cerning a terminal Alzheimer's patient and results may
differ with other cases.
Conclusion
This descriptive study is the first report to analyze the
characteristics of ethics consultation between two Ameri-
can and two Japanese experts. Our findings suggest that
consensus building through an "ethics facilitation"
approach may be a commonality to the practice of ethics
consultation in the US and Japan, while differences
emerged in terms of recommendations, surrogate assess-
ment, and assessing treatments. Further research is needed
to appreciate differences not only among different nations
including, but not limited to, countries in Europe, Asia
and the Americas, but also within each country.
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